Barclays’s Audentes Therapeutics, Inc BOLD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-160,578
| Closed | -$9.61M | – | 4115 |
|
|
2019
Q4 | $9.61M | Buy |
160,578
+122,192
| +318% | +$7.31M | 0.01% | 867 |
|
|
2019
Q3 | $1.08M | Buy |
38,386
+6,861
| +22% | +$193K | ﹤0.01% | 2218 |
|
|
2019
Q2 | $1.19M | Buy |
31,525
+7,038
| +29% | +$266K | ﹤0.01% | 2208 |
|
|
2019
Q1 | $955K | Buy |
24,487
+12,523
| +105% | +$488K | ﹤0.01% | 2177 |
|
|
2018
Q4 | $255K | Sell |
11,964
-7,932
| -40% | -$169K | ﹤0.01% | 2623 |
|
|
2018
Q3 | $788K | Buy |
19,896
+15,039
| +310% | +$596K | ﹤0.01% | 2401 |
|
|
2018
Q2 | $186K | Sell |
4,857
-8,041
| -62% | -$308K | ﹤0.01% | 2779 |
|
|
2018
Q1 | $387K | Buy |
12,898
+9,763
| +311% | +$293K | ﹤0.01% | 2452 |
|
|
2017
Q4 | $98K | Sell |
3,135
-949
| -23% | -$29.7K | ﹤0.01% | 3019 |
|
|
2017
Q3 | $114K | Buy |
4,084
+3,322
| +436% | +$92.7K | ﹤0.01% | 2655 |
|
|
2017
Q2 | $15K | Sell |
762
-4,612
| -86% | -$90.8K | ﹤0.01% | 3356 |
|
|
2017
Q1 | $91K | Buy |
5,374
+4,030
| +300% | +$68.2K | ﹤0.01% | 2873 |
|
|
2016
Q4 | $23K | Buy |
+1,344
| New | +$23K | ﹤0.01% | 3056 |
|